Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Neo Biopharm ApS
APS
Active
CVR 42875708
Kildegårdsvej 18D, 2900
Hellerup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Neo Biopharm ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
3M
2M
1M
1M
0M
2M
2022
1M
-50%
2023
0M
-100%
2024
0M
0%
2025
EBITDA
DKK millions
3M
2M
1M
1M
0M
2M
2022
0M
-100%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Gross profit
2.458
528
206
-357
Staff expenses
-0
-0
-0
-0
EBITDA
2.358
335
206
-357
Depreciation & amort.
-0
-0
-0
-0
EBIT
2.358
335
206
-357
Net financials
-16
-19
-11
9
Profit before tax
2.342
316
195
-348
Tax
517
72
38
-76
Net profit
1.825
244
157
-271
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
2.593
2.745
2.513
1.994
Equity
1.865
2.109
2.266
1.994
Long-term debt
0
0
0
0
Short-term debt
728
637
247
0
Total debt
728
637
247
0
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-35730800.0%
This company
2022
2025
Equity ratio
100.0%
This company
38.2%
Market median
162% above market
2022
2025
Return on equity
-13.6%
This company
18.4%
Market median
174% below market
2022
2025
Net profit margin (of gross profit)
-27140300.0%
This company
2022
2025
Asset turnover (of gross profit)
-0.18×
This company
2022
2025
Debt / equity
0.00×
This company
0.62×
Market median
100% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-11-23 – 2022-12-31
View
PDF
More on Neo Biopharm ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
